Cargando…

Severe asthma remaining well‐controlled after mepolizumab discontinuation: A case report and literature review

Mepolizumab, a humanized anti‐IL‐5 monoclonal antibody used for severe asthma, results in a reduced rate of asthma exacerbation, improved lung function, reduced oral corticosteroid use, and improved quality of life. A 62‐year‐old man using high‐dose inhaled corticosteroid visited our hospital becaus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuyama, Takahiro, Tomioka, Yuya, Matsuyama, Hiromi, Kamenohara, Yusuke, Tanigawa, Kengo, Dotake, Yoichi, Hagihara, Yoko, Takagi, Koichi, Machida, Kentaro, Inoue, Hiromasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173049/ https://www.ncbi.nlm.nih.gov/pubmed/37180095 http://dx.doi.org/10.1002/rcr2.1158

Ejemplares similares

The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma
por: Matsuyama, Takahiro, et al.
Publicado: (2022)

The Functional Role of Group 2 Innate Lymphoid Cells in Asthma
por: Matsuyama, Takahiro, et al.
Publicado: (2023)

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase‐positive lung cancer
por: Tanigawa, Kengo, et al.
Publicado: (2019)

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets
por: Tanigawa, Kengo, et al.
Publicado: (2023)

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma
por: Tomioka, Yuya, et al.
Publicado: (2023)

Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review
por: Matsuyama, Takahiro, et al.
Publicado: (2023)

Association Between Procrastination in Childhood and the Number of Remaining Teeth in Japanese Older Adults
por: Shimamura, Moemi, et al.
Publicado: (2022)

Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials
por: Ayabe, Kengo, et al.
Publicado: (2016)

Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
por: Ortega, Hector, et al.
Publicado: (2019)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
por: Ueno, Masanobu, et al.
Publicado: (2022)

Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
por: Hamada, Toru, et al.
Publicado: (2023)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
por: Ueno, Masanobu, et al.
Publicado: (2021)

Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma
por: Mizuno, Keiko, et al.
Publicado: (2021)

Mepolizumab and COPD in Real Life
por: Revuelta-Salgado, Fernando, et al.
Publicado: (2021)

A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab
por: Terashima, Takeshi, et al.
Publicado: (2018)

Ancient DNA of Phoenician remains indicates discontinuity in the settlement history of Ibiza
por: Zalloua, Pierre, et al.
Publicado: (2018)

Severe Pediatric Asthma Therapy: Mepolizumab
por: Ullmann, Nicola, et al.
Publicado: (2022)

Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature
por: Hirota, Shuko, et al.
Publicado: (2018)

Discontinuation or reduction in benzodiazepine use by treatment with the traditional herbal medicine Hangekobokuto, case reports
por: Yoshinaga, Ryo, et al.
Publicado: (2020)

Association between number of remaining teeth and healthy aging in Japanese older people: The Ohsaki Cohort 2006 Study
por: Matsuyama, Sanae, et al.
Publicado: (2021)

Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study
por: Takahashi, Koichiro, et al.
Publicado: (2023)

Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
por: Yamane, Takashi, et al.
Publicado: (2023)

Successful Treatment with Mepolizumab for Coronary Spastic Angina Associated with Eosinophilic Granulomatosis with Polyangiitis
por: Takigawa, Yuki, et al.
Publicado: (2023)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

May mepolizumab used in asthma correct subfertility?
por: Ozden, Guzin, et al.
Publicado: (2021)

The validation and reliability of a Japanese version of the Problematic Online Gaming Questionnaire (POGQ-J)
por: Inoue, Kazuya, et al.
Publicado: (2021)

Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma
por: Kobayashi, Konomi, et al.
Publicado: (2021)

Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab
por: Kay, Dana, et al.
Publicado: (2018)

Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab
por: Herout, Sandra, et al.
Publicado: (2018)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
por: Pradhan, Ravi Ranjan, et al.
Publicado: (2019)

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
por: Long, Gabriella, et al.
Publicado: (2018)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
por: Mkorombindo, Takudzwa, et al.
Publicado: (2019)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
por: Yancey, Steven W., et al.
Publicado: (2019)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
por: Otoshi, Ryota, et al.
Publicado: (2019)

Characteristics of new adult users of mepolizumab with asthma in the USA
por: Wu, Ann Chen, et al.
Publicado: (2021)

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
por: Pavord, Ian D, et al.
Publicado: (2021)

Daily Physical Activity in Asthma and the Effect of Mepolizumab Therapy
por: Panagiotou, Marios, et al.
Publicado: (2022)

Mepolizumab induced palmoplantar psoriasis: A case report
por: Artosi, Fabio, et al.
Publicado: (2023)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
por: Haldar, Pranabashis
Publicado: (2017)

Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
por: Condreay, Lynn D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r3lajcdj75401l37082s1p7vtp